Back to search

Article

Tumor Marker–Guided Precision BNCT for CA19-9–Positive Cancers: A New Paradigm in Molecularly Targeted Chemoradiation Therapy

2025-08-29

Abstract excerpt

<title>Abstract</title> <p>Background Boron neutron capture therapy (BNCT) is a molecularly targeted chemoradiation modality that relies on boron delivery agents such as p-borophenylalanine (BPA), which require LAT1 (L-type amino acid transporter 1) for tumor uptake. However, the limited efficacy of BPA in LAT1-low tumors restricts its therapeutic scope. To address this limitation, we developed a tumor marker–gui...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
37af963e-54a0-56a9-b29b-124a9544eca0
DOI
10.21203/rs.3.rs-7314409/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor Marker–Guided Precision BNCT for CA19-9–Positive Cancers: A New Paradigm in Molecularly Targeted Chemoradiation TherapyDOI 10.21203/rs.3.rs-7314409/v1
Select a neighboring publication to make it the new centre.